Ahmed Abuzaanona

Ahmed Abuzaanona practices at Sanford Fargo Hospice in Fargo, North Dakota.

Ahmed Abuzaanona's NPI, 1104209378, was assigned on July 6, 2015. Ahmed Abuzaanona holds North Dakota license 17378.

Ahmed Abuzaanona's primary practice is Sanford Fargo Hospice, at 801 Broadway North, Fargo, ND 58102 in Cass County. The practice phone is (701) 234-7550.

Ahmed Abuzaanona's primary practice is Sanford Fargo Hospice in Fargo, North Dakota. Ahmed Abuzaanona is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Ahmed Abuzaanona to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ahmed Abuzaanona practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Ahmed Abuzaanona's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Ahmed Abuzaanona is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Ahmed Abuzaanona's licenses on file in 2 states: North Dakota and Michigan.

CMS data shows 7,650 Medicare services from Ahmed Abuzaanona across 30 procedure codes in 2024, for 3,450 Medicare patients. Medicare paid $207,308 for them.

CMS counts 3,450 Medicare patients who saw Ahmed Abuzaanona in 2024. The largest group is 65 to 74, with 1,282 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ahmed Abuzaanona's median patient age at 73, with 48% women.

In 2024, Ahmed Abuzaanona wrote 2,670 Medicare Part D claims for 642 patients. 85% of them were for generic drugs. CMS names the drug for 2,531 of them, across 32 drugs with 11 or more claims each, at $750,224 in total drug cost. In 2023, CMS named 2,174 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Ahmed Abuzaanona for performance year 2024, reported as part of a group. Ahmed Abuzaanona accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ahmed Abuzaanona as offering telehealth.

Dmand AI links 2 papers to Ahmed Abuzaanona in 2018. Ahmed Abuzaanona's most frequent co-authors are David E. Lanfear, MD, Phillip D. Levy, MD and Joseph Benjamin Miller, MD.

CMS Open Payments shows 37 general payments to Ahmed Abuzaanona from 6 drug and device companies from 2019 to 2024. Travel and lodging make up the largest share, 69% of the total. Abbott Laboratories paid the most, $1,387.